# Contrast Enhancement Phases > Contrast enhancement phases for NEET-PG Radiology: arterial, portal venous and delayed timing, HCC washout, haemangioma fill-in and renal phases. - Canonical URL: https://prepelephant.com/topics/neet-pg/radiology/contrast-enhancement-phases - Exam / course: NEET-PG · Subject: Radiology - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Contrast Enhancement Phases", PrepElephant, https://prepelephant.com/topics/neet-pg/radiology/contrast-enhancement-phases ## Direct answer Timing of acquisition, not scanner power, decides what a contrast CT can diagnose. After an intravenous bolus, the late arterial phase at roughly 25-35 seconds shows hypervascular lesions at their brightest, the portal venous phase at 60-70 seconds is the routine parenchymal workhorse, and delayed phases at 3-5 minutes expose washout and fibrotic retention. Hepatocellular carcinoma's signature is arterial hyperenhancement with portal or delayed washout; haemangioma shows peripheral, discontinuous, nodular enhancement progressing to complete fill-in; cholangiocarcinoma enhances progressively and retains contrast on delay; focal nodular hyperplasia lights up early with a central scar that enhances late. In the kidney, the nephrographic phase (90-120 seconds) detects renal cell carcinoma best, while the excretory phase outlines the collecting system. ## What you must remember - **Phase clock:** late arterial about 25-35 seconds, portal venous 60-70 seconds, equilibrium or delayed 3-5 minutes — quote seconds, not adjectives. - **HCC signature:** intense arterial enhancement with washout on portal venous or delayed phases in a cirrhotic liver — the LI-RADS backbone; capsule appearance on delay further upgrades the category. - **Haemangioma:** peripheral nodular discontinuous enhancement with centripetal fill-in persisting on delay, isodense to the aorta at each phase — blood-pool behaviour, not tumour behaviour. - **Focal nodular hyperplasia versus adenoma:** FNH is homogeneously bright arterial with a central scar enhancing on delay; adenomas enhance strongly but variably and carry rupture risk (oral contraceptive link), a classic pair in young women. - **Cholangiocarcinoma:** hypovascular early with progressive, delayed retention (fibrous stroma), plus delayed capsular retraction — the mirror image of HCC kinetics. - **Renal phases:** corticomedullary 25-40 seconds (vascular anatomy), nephrographic 90-120 seconds (most sensitive for RCC), excretory 3-5 minutes (collecting system, urothelial lesions); a lesion enhancing over 20 HU from baseline is solid, not cystic. - **Adrenal washout:** on a 15-minute delayed sequence, an adenoma washes out over 60% absolute (over 40% relative) versus persistent enhancement in metastases — the workhorse of incidentaloma characterisation. - **Pancreatic protocol:** a dedicated pancreatic phase around 35-45 seconds maximises parenchymal enhancement and tumour-to-gland contrast for ductal adenocarcinoma. ## One lesion, four clocks A 56-year-old cirrhotic under hepatoma surveillance. On the arterial phase, a 2.5 cm right lobe nodule blazes brighter than the surrounding liver; on the portal venous and delayed sequences it falls duller than background — enhancement then washout, the kinetic fingerprint of hepatocellular carcinoma, and under LI-RADS a category 5 lesion in a cirrhotic liver that can be diagnosed radiologically without biopsy. Substitute the contrast pair the exam prefers: the same nodule showing peripheral nodular enhancement at the margins at 30 seconds, coalescing centrally by 3 minutes and staying isodense with blood pools at every time point — haemangioma, biopsy contraindicated (bleeding risk), no further work-up. Third substitution: an ill-defined left lobe mass, hypodense arterial, gradually denser on each delayed image with overlying capsular retraction — cholangiocarcinoma, and the surgical question shifts from liver resection to biliary drainage and staging. The physics is identical in all three; only the clock position of the photograph changes, which is why "which phase" is the first question a radiologist asks before naming any liver lesion. ## Phase-mismatch mistakes Treating arterial hyperenhancement as synonymous with malignancy forgets that the arterial phase also displays benign physiology — FNH, adenoma, arterioportal shunts and even focal fat sparing can glow; washout behaviour, not brightness alone, carries the diagnostic weight. Second, phase-mismatch errors: a "hypervascular renal lesion" read on a corticomedullary study may be merely normal medulla waiting for the nephrographic phase, which is precisely why renal mass protocols mandate the 90-120 second acquisition. Third, timing vocabulary confusion — "arterial phase" in an aortic-dissection or circle-of-Willis study means about 20-25 seconds (pure arterial), whereas hepatic "late arterial" is nearer 35 seconds after arterial arrival; exam stems exploit exactly this gap. Also remember that poor cardiac output and central venous access shift every clock, so a "badly timed" study is a physiological reading, not a failed one. ## Frequently asked questions ### What are the standard abdominal contrast phases and their timings? Late arterial at roughly 25-35 seconds, portal venous at 60-70 seconds, and delayed at 3-5 minutes, each answering a different lesion question. ### What enhancement pattern characterises hepatocellular carcinoma? Arterial phase hyperenhancement followed by washout relative to background liver on portal venous or delayed images, often with an enhancing capsule on delay — the LI-RADS major criteria. ### How does a haemangioma enhance? Peripheral, discontinuous, nodular enhancement progressing centripetally to complete fill-in on delayed images, tracking blood-pool density at every phase. ### Which phase best detects renal cell carcinoma? The nephrographic phase at 90-120 seconds, when medulla and cortex are uniformly enhanced and even small hypovascular tumours stand out as hypoattenuating lesions. ### What is adrenal washout characterisation? An adrenal mass measured at baseline and 15 minutes' delay: adenomas lose over 60% absolute (over 40% relative) attenuation, while metastases retain contrast — separating the incidentaloma without biopsy.